Patents by Inventor Laurence Salin

Laurence Salin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Inflammatory Lesions of Rosacea with Ivermectin
    Publication number: 20220347198
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: July 7, 2022
    Publication date: November 3, 2022
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Nathalie Sordello Wagner, Alexandre Kaoukhov, Michael Graeber, Laurence Salin, Michel Poncet, Philippe Briantais, Khaled Benkali
  • Treatment of Inflammatory Lesions of Rosacea with Ivermectin
    Publication number: 20210177882
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 17, 2021
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20200000835
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: August 23, 2019
    Publication date: January 2, 2020
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • Treatment of papulopustular rosacea with ivermectin
    Patent number: 10206939
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: February 19, 2019
    Assignee: Galderma S.A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Alexandre Kaoukhov, Michael Graeber, Michel Poncet, Philippe Briantais, Laurence Salin
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20180264021
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: May 24, 2018
    Publication date: September 20, 2018
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Michel PONCET, Philippe BRIANTAIS, Laurence SALIN
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20180207188
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: March 1, 2018
    Publication date: July 26, 2018
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Michel PONCET, Philippe BRIANTAIS, Laurence SALIN
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20180177813
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: February 22, 2018
    Publication date: June 28, 2018
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • Treatment of papulopustular rosacea with ivermectin
    Patent number: 9782425
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: October 10, 2017
    Assignee: Galderma S.A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Alexandre Kaoukhov, Michael Graeber, Laurence Salin, Michel Poncet, Philippe Briantais
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20160184342
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: July 8, 2014
    Publication date: June 30, 2016
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20160175337
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 23, 2016
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Michel PONCET, Philippe BRIANTAIS, Laurence SALIN
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20160158263
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: July 8, 2014
    Publication date: June 9, 2016
    Inventors: Jean JACOVELLA, Jian-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20160143935
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: December 17, 2015
    Publication date: May 26, 2016
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Michael GRAEBER, Alexandre KAOUKHOV, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • Treatment of inflammatory lesions of rosacea with ivermectin
    Patent number: 9233117
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 12, 2016
    Assignee: Galderma S. A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Nathalie Sordello Wagner, Michael Graeber, Alexandre Kaoukhov, Laurence Salin, Michel Poncet, Philippe Briantais, Khaled Benkali
  • Treatment of papulopustular rosacea with ivermectin
    Patent number: 9233118
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 12, 2016
    Assignee: Galderma S.A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Alexandre Kaoukhov, Michael Graeber, Michel Poncet, Philippe Briantais, Laurence Salin
  • Treatment of type 2 diabetes
    Patent number: 8202884
    Abstract: The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: June 19, 2012
    Assignee: Neurosearch A/S
    Inventors: Klaus Dugi, Andreas Raschig, Juergen Reess, Frank Berger, Laurence Salin
  • COMBINATION WITH AN EXTENDED RELEASE TABLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20100092554
    Abstract: The present invention is directed to a combination of an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof with a conventional treatment option of Parkinson's Disease.
    Type: Application
    Filed: April 22, 2008
    Publication date: April 15, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Juergen Reess, Laurence Salin
  • Treatment of Diabetes
    Publication number: 20090018159
    Abstract: The invention relates to the use of a monoamine neurotransmitter re-uptake inhibitor comprising a 2,3-disubstituted tropane moiety, or a tautomer, a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof for the manufacture of a medicament for the treatment of diabetic patients.
    Type: Application
    Filed: October 31, 2006
    Publication date: January 15, 2009
    Applicant: NeuroSearch A/S
    Inventors: Klaus Dugi, Andreas Raschig, Juergen Reess, Frank Berger, Laurence Salin